| IND | indomethacin; industrial medicine; investigational new drug |
|---|---|
| ind | indirect; induction |
| ref | ind refractive index |
| SCI | Science Citation Index; spinal cord injury; structured clinical interview |
| Sci | science, scientific |
| A.I.I.M.S. | All India Institute of Medical Sciences |
|---|---|
| RES | Reserpine |
| RES | Reticulo Endothelial System |
| IND | Indomethacin |
| IND | Intestinal Neuronal Dysplasia |
| RES | <abbreviation> Reticuloendothelial system. (05 Mar 2000) |
|---|---|
| india | A country in Southern Asia; the two peninsulas of Hither and Farther India; in a restricted sense, Hither India, or Hindostan. India ink, a nearly black pigment brought chiefly from China, used for water colours. It is in rolls, or in square, and consists of lampblack or ivory black and animal glue. Called also China ink. The true India ink is sepia. See Sepia. India matting, floor matting made in China, India, etc, from grass and reeds; also called Canton, or China, matting. India paper, a variety of Chinese paper, of smooth but not glossy surface, used for printing from engravings, woodcuts, etc. India proof, a proof impression from an engraved plate, taken on India paper. India rubber. See Caoutchouc. <botany> India-rubber tree, any tree yielding caoutchouc, but especially the East Indian Ficus elastica, often cultivated for its large, shining, elliptical leaves. See: Indian. Source: Websters Dictionary (01 Mar 1998) |
| India ink capsule stain | <technique> A negative stain for crystal bacteria in which cells appear purple (Gram's crystal violet) and the capsules appear clear against a dark background. (05 Mar 2000) |
| ind | Investigational New Drug An IND application containing laboratory study results of the drug candidate is submitted to the FDA to request permission to conduct studies in humans. (14 Nov 1997) |
| ind status | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| treatment ind | An FDA-approved program that allows a physician to procure an experimental drug for seriously ill patients who have no other treatment options in exchange for data on the safety and perhaps the effectiveness of the drug. See: compassionate use, parallel track, expanded access. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|